0481216 MES MES MES MES Anti-Tumor Immune ActivityBreast Cancer PrognosisBreast Cancer ReceptorsBreast Cancer Signaling PathwaysBreast Cancer SubtypingImmune Cell AbundanceInhibitory Immune MechanismsInhibitory Immune SignalingInhibitory MetabolismStromal FactorsTumor ImmunogenicityTumor Mutational ResponseTumor RegulationLumALumBHER2-EBasalCytotoxicityMHC2TISIFN GammaRORERBB2PGRARESR1CDK6 ExpressionER SignalingPTENClaudin-LowMast CellsCytotoxic CellsCD8 T-CellsMacrophagesTregB7-H3PD-L1TGF-BetaIDO1PD-L2TIGITInflammatory ChemokinesHypoxiaEndothelial CellsStromaAPMHRDBRCAnessBC p53BC ProliferationRb1Cell AdhesionApoptosisDifferentiationMammary StemnessSOX2FOXA1